Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery
NCT ID: NCT03057678
Last Updated: 2022-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2021-12-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Cochlear Implantation: Implementation of Technique
NCT01460823
Cone-beam CT in the Diagnosis and Surgical Treatment of Otosclerosis.
NCT05921578
Hearing Aid Versus Surgical Rehabilitation as Treatment of Otosclerosis: Pilot Study
NCT02456272
Impact of Microphone Positioning on Auditory Performance in Cochlear Implant Users
NCT04677517
Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma
NCT02948790
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
TANR surgery is performed to remove benign tumors on the auditory nerve which can cause severe hearing and balance problems if not removed. The current standard of care is a mastoidectomy, followed by a labyrinthectomy (excision of the labyrinth of the inner ear) to gain access to the skull base, specifically the internal auditory canal (IAC), where tumors are located.
Several critical anatomical structures are embedded in the mastoid bone, including the facial nerve, which controls motion of the face, large blood vessels such as the carotid artery and intracranial continuation of the jugular vein, and the tegmen, which is the boundary between the mastoid and the brain. Surgeons are specially trained to recognize and avoid these structures when drilling. Drilling for TANR surgery often takes several hours due to slow advancement of the drill through hard bone in the labyrinth region. After this drilling is when the most delicate and critical portion of the surgery begins i.e. removal of the acoustic neuroma. The investigators hypothesize that a robot, guided by pre-operative images, can perform the drilling for TANR surgery while preserving safe margins around the critical structures thus enabling surgeons to focus on the delicate, final stage of TANR surgery.
There are several robotic systems available for orthopedic drilling procedures such as joint arthroplasty and resurfacing. These systems include the RIO System (Stryker Mako, Ft. Lauderdale, FL, USA), the ROBODOC Surgical System (Think Surgical Corp., Fremont, CA, USA) and the CASPAR (URS Ortho GMBH \& Co. KG, Rastatt, Germany). However, these systems have not been shown accurate enough to perform TANR surgery safely, and rely on expensive image guidance systems to continuously track the patient's position relative to the robot, in order to ensure that the robot-guided drill stays within safe margins.
The investigators previously designed a small light-weight robot that can be attached to the bone of a patient's head, and provide the required accuracy for TANR surgery without an expensive image guidance system.
To reach an entire mastoidectomy volume for TANR surgery, our robot must be correctly positioned relative to a patient's temporal bone anatomy. The investigators hypothesize that a rigid fixture, which the investigators call a pre-positioning frame (PPF), can correctly position our robot to complete drilling for TANR surgery on the patient population. The goal of this study is to investigate the first step in implementing this system by attaching a PPF to a patient who is undergoing a standard TANR surgery in order to better understand the time it takes to do this step and optimize the surgical workflow.
The PPF, attaches directly to the participants head behind the ear, using bone screws adapted from cranial reconstruction hardware. These bone screws are typically used in this area of the skull and placed at a similar penetration depth of 3.5 mm. The safety margin from tip of the screw to the inside skull surface will be 0.25mm In a future study, the robot would then attach to fiducial markers on the top surface of the PPF. Our current PPF design incorporates data from ten robotic drilling experiments. Six trials were performed on excised temporal bones, and four were performed on full cadaver heads. Using results from these experiments, the investigators improved the shape of the PPF to optimally reach the range of planned TANR mastoidectomy volumes, and also improved the legs of the PPF to facilitate rapid and secure implantation of bone screws.
The surgical workflow the investigators plan for a full robotic mastoidectomy will be described here for context, but to be clear, steps 7, 8, and 10 will not be performed in the proposed study.
1. Prior to surgery, a surgeon manually segments a mastoidectomy volume in a preoperative CT image using investigational software created for this purpose.
2. During surgery, the PPF is anchored to the temporal bone with self-drilling bone screws.
3. An intraoperative CT scan is acquired of the participants's head with the PPF attached using a portable CT scanner.
4. The intraoperative CT image is registered to the preoperative CT and the pre-operative segmentations are transformed to the intraoperative CT using the registration.
5. Fiducial markers on the PPF are localized in the intraoperative CT image, allowing the pre-operative segmentation data to be transformed to the intraoperative CT image space.
6. Robot motion is automatically planned using investigational mastoidectomy planning software.
7. (The robot is fastened to the fiducial markers on the PPF, and is activated to execute the drill trajectory. The surgeon retains supervisory control over the robot and can stop or alter its speed if necessary).
8. (The robot is removed from the PPF following completion of drilling).
9. The PPF is removed from the participant by loosening the bone screws.
10. (The surgeon completes the manual surgical actions that follow mastoidectomy drilling, such as removal of IAC tumors.) The investigators plan to clinically validate the improved PPF design by performing the steps above (excluding steps 7, 8, and 10) on ten participants. Note that the PPF will be removed directly after step 5 when the CT image has been registered. Using previously developed robotic mastoidectomy planning software (step 6), the investigators will calculate the percentage of each TANR mastoidectomy that is reachable for an attached PPF configuration. Step 6 will be done once the images have been collected and will not impact the clinical procedure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Testing of Pre-Positioning Frame
Placement of bone screws, CT scanning, Surgical planning, Robot motion planning
Testing of Pre-Positioning Frame
Placement of bone screws, CT scanning, Surgical planning, Robot motion planning
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Testing of Pre-Positioning Frame
Placement of bone screws, CT scanning, Surgical planning, Robot motion planning
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Preop Head CT scan as part of routine care.
* Skull thickness a minimum of 3.75mm in planned attachment areas.
Exclusion Criteria
* Patients with severe comorbidities, such as chronic otitis media, history of stroke, brain trauma, or hydrocephalus.
* Patients with a history of allergic reactions to lidocaine.
* Patients with severe anatomical abnormality of the temporal bone.
* Patients with history of allergic reaction to titanium, because the bone screws used in this study are made of a titanium alloy.
* Patients who are at unacceptable risk for general anesthesia.
* Patients who are at unacceptable risk for the intraoperative CT scan(s).
* Patients who are unable to give informed consent.
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert F. Labadie
Vice Chair, Chief Research Officer, Professor of Otolaryngology-Head and Neck Surgery, Professor of Biomedical Engineering
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert F. Labadie, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Robert J. Webster, PhD
Role: STUDY_DIRECTOR
Vanderbilt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
151347
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.